Literature DB >> 9989619

Predominance of neuronal mRNAs in individual Alzheimer's disease senile plaques.

S D Ginsberg1, P B Crino, S E Hemby, J A Weingarten, V M Lee, J H Eberwine, J Q Trojanowski.   

Abstract

The sequestration of RNA in Alzheimer's disease (AD) senile plaques (SPs) and the production of intraneuronal amyloid-beta peptides (Abeta) prompted analysis of the mRNA profile in single immunocytochemically identified SPs in sections of AD hippocampus. By using amplified RNA expression profiling, polymerase chain reaction, and in situ hybridization, we assessed the presence and abundance of 51 mRNAs that encode proteins implicated in the pathogenesis of AD. The mRNAs in SPs were compared with those in individual CA1 neurons and the surrounding neuropil of control subjects. The remarkable demonstration here, that neuronal mRNAs predominate in SPs, implies that these mRNAs are nonproteinaceous components of SPs, and, moreover, that mRNAs may interact with Abeta protein and that SPs form at sites where neurons degenerate in the AD brain.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9989619

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  41 in total

1.  Expression profiling with oligonucleotide arrays: technologies and applications for neurobiology.

Authors:  Timothy J Sendera; David Dorris; Ramesh Ramakrishnan; Allen Nguyen; Dionisios Trakas; Abhijit Mazumder
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

Review 2.  Functional genomics and psychiatric illness.

Authors:  Wendy Hasenkamp; Scott E Hemby
Journal:  Prog Brain Res       Date:  2002       Impact factor: 2.453

Review 3.  Gene expression profiling with DNA microarrays: advancing our understanding of psychiatric disorders.

Authors:  Julie Pongrac; Frank A Middleton; David A Lewis; Pat Levitt; Károly Mirnics
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

4.  Neuron-specific age-related decreases in dopamine receptor subtype mRNAs.

Authors:  Scott E Hemby; John Q Trojanowski; Stephen D Ginsberg
Journal:  J Comp Neurol       Date:  2003-02-03       Impact factor: 3.215

Review 5.  Expression profile analysis of neurodegenerative disease: advances in specificity and resolution.

Authors:  Jason G Glanzer; Phillip G Haydon; James H Eberwine
Journal:  Neurochem Res       Date:  2004-06       Impact factor: 3.996

Review 6.  Gene expression profiling in neurological disorders: toward a systems-level understanding of the brain.

Authors:  Sergio E Baranzini
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

Review 7.  Single cell gene expression profiling in Alzheimer's disease.

Authors:  Stephen D Ginsberg; Shaoli Che; Scott E Counts; Elliott J Mufson
Journal:  NeuroRx       Date:  2006-07

8.  Time-dependent DNA condensation induced by amyloid beta-peptide.

Authors:  Haijia Yu; Jinsong Ren; Xiaogang Qu
Journal:  Biophys J       Date:  2006-10-06       Impact factor: 4.033

9.  Selective incorporation of polyanionic molecules into hamster prions.

Authors:  James C Geoghegan; Pablo A Valdes; Nicholas R Orem; Nathan R Deleault; R Anthony Williamson; Brent T Harris; Surachai Supattapone
Journal:  J Biol Chem       Date:  2007-10-16       Impact factor: 5.157

Review 10.  Cocainomics: new insights into the molecular basis of cocaine addiction.

Authors:  Scott E Hemby
Journal:  J Neuroimmune Pharmacol       Date:  2010-03       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.